Patriot News Organization

(HealthDay)—After nearly dying from a severe case of COVID-19, a young male patient received a successful heart transplant even as he was recuperating from his infection while on a ventilator, a new case study reports. The transplant was performed on…

NEW YORK (Reuters Health) – A new MRI scanner that can be built at low cost but produces high-quality neuroimaging could improve access to the technology in low- and middle-income countries, researchers suggest. Because the scanner needs no shield and…

Boris Johnson urges UK to ‘get boosted now’ to fight Omicron We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based…

Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins, today announces it has raised EUR 30.6 million in an oversubscribed Series A financing. The funds will be used to further develop…

GENEVA (Reuters) – COVID-19 vaccines appear slightly less effective in preventing severe disease and death but do provide “significant protection,” the World Health Organization (WHO) said on Tuesday. The Omicron variant first detected in South Africa and Hong Kong last…

Omicron variant: Doctor warns of risk of reinfection We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding….

When the holiday season rolls around, will you get to relax, or do you let work creep into your down time? If you fit in the latter category and can’t seem to keep work at bay, you may be putting…

Sleep disorders and insufficient sleep are major global problems contributing to, e.g., increased health care costs and sick leaves, and reduced quality of life. According to recent estimates, sleep apnea alone affects approximately 1 billion people worldwide, and up to…

NEW YORK (Reuters) – All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detected Omicron variant of the coronavirus in laboratory testing, but a booster dose likely restores most of the protection, according to a study…

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info…